Delivery Order SPE2DB20D3103-SPE2DB25FQ1A8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,472.02 to AmerisourceBergen Drug Corp for Loryna 3 mg-0.02 mg tablets (28-count packaging) to be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed price delivery order with no set-aside designation, awarded competitively on August 27, 2025, with an ultimate completion date of August 28, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,722.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Loryna 3 mg-0.02 mg tablets (28-count packaging) under contract number 4568916705. The order, placed without a set-aside designation, was competitively awarded and completed on July 29, 2025, with an ultimate completion date of July 30, 2025. Performance of this delivery order is based in Conshohocken, Pennsylvania, the company's corporate headquarters location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Loryna 3 mg-0.02 mg tablets (28-count packaging) with a ceiling value of $1,366.30. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, and performance will take place at the contractor's facility in Conshohocken, Pennsylvania. The order is expected to be completed by August 18, 2025. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Loryna 3 mg-0.02 mg tablets in quantities of 28 with a ceiling value of $9,337.76. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a competitively awarded non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,641.63, is for the delivery of the drug Loryna 3 mg-0.02 mg tablet in quantities of 28 tablets. The contract is a Firm Fixed Price Delivery Order, with a completion date of November 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,327.36, is for the delivery of the prescription medication Loryna 3 mg-0.02 mg tablets. This is a firm fixed-price delivery order contract with an ultimate completion date of August 12, 2024. Amerisourcebergen holds a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,820.83 Firm Fixed Price Delivery Order contract is for the supply of Loryna 3 mg-0.02 mg tablets. The award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the...
- The Defense Logistics Agency awarded a $2,851 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under the terms of the firm fixed price contract, Amerisourcebergen will supply 4561778187 Loryna 3 MG-0.02 MG tablets to the DLA. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days from August 11-14, 2023. As a major distributor of pharmaceuticals to the Department of Defense, Amerisourcebergen is well...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,832.68 Firm Fixed Price Delivery Order covers the supply of Loryna 3 mg-0.02 mg tablets to support military healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $1,793.56 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S. This delivery order was issued under an existing indefinite delivery contract (IDC) with Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025....
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ1A8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,963.54 to AmerisourceBergen Drug Corp for the supply of Loryna 3 mg-0.02 mg tablets (28-count packages) with a completion date of September 2, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $1 billion ceiling value and extends through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to military and veteran healthcare systems. This delivery order exemplifies AmerisourceBergen's extensive role within the federal pharmaceutical supply chain, particularly through its comprehensive IDC vehicle that enables flexible fulfillment of medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's competitive award history and demonstrated capability to manage orders ranging from minimal to substantial values underscore its position as a strategic pharmaceutical prime vendor for federal defense medical supply requirements. The DLA's ongoing efforts to establish multi-award Pharmaceutical Prime Vendor Global Program Generation V contracts reflect the agency's commitment to maintaining robust supply chain resilience through partnerships with qualified distributors like AmerisourceBergen.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/29/25 |